There's a new tweet from Prusty suggesting he has found a biomarker.
"We will announce a biomarker for
#MECFS and
#LongCovid very soon. A very interesting piece of the puzzle to unfold in coming weeks. Knowingly I did not use the word 'Novel Biomarker' as a lot is known about it and that is actually a very good news. Fingers crossed!"
This is probably linked to the patients vs controls heatmap he tweeted in December: he's found *somethiing* on which patients and controls differ.
In some other tweets he has been suggesting that he isn't using any whiz-bang new tricks, just looking at known entities, using known techniques.
He also hints that it has something to do with clotting.
The info will come out on May 11 when he presents at a MECFS symposium in Berlin. That is 42 days away!
https://cfc.charite.de/fileadmin/us...anding_Page/MECFS-Conference-2023_Digital.pdf
Looks like there will be a free livestream of that event:
https://www.medpoint-gmbh.de/me-cfs-conference-2023
There will then be more information in June when he attends the IIMEC conference in Cambridge.
http://www.investinme.org/IIMEC15.shtml